Satellos Bioscience Inc. (MSCL.TO)
CAD 0.89
(-4.3%)
CAD 0.89
(-4.3%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -15.46 Million CAD | -83.47% |
| 2022 | -8.42 Million CAD | -77.91% |
| 2021 | -4.73 Million CAD | -206.57% |
| 2020 | -1.54 Million CAD | 22.72% |
| 2019 | -1.99 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -8.25 Million CAD | -32.12% |
| 2024 Q2 | -6.67 Million CAD | 19.09% |
| 2023 Q3 | -4.48 Million CAD | -59.67% |
| 2023 FY | -15.46 Million CAD | -83.47% |
| 2023 Q2 | -2.81 Million CAD | -68.71% |
| 2023 Q1 | -1.66 Million CAD | -7623.82% |
| 2023 Q4 | -6.24 Million CAD | -39.22% |
| 2022 Q4 | 22.14 Thousand CAD | 101.2% |
| 2022 FY | -8.42 Million CAD | -77.91% |
| 2022 Q3 | -1.83 Million CAD | 0.0% |
| 2021 FY | -4.73 Million CAD | -206.57% |
| 2020 FY | -1.54 Million CAD | 22.72% |
| 2019 FY | -1.99 Million CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Appili Therapeutics Inc. | -8.05 Million CAD | -92.082% |
| Eupraxia Pharmaceuticals Inc. | -36.89 Million CAD | 58.091% |
| Helix BioPharma Corp. | -9.37 Million CAD | -65.009% |
| Microbix Biosystems Inc. | -2.73 Million CAD | -465.079% |
| Medicenna Therapeutics Corp. | -19.66 Million CAD | 21.36% |
| Oncolytics Biotech Inc. | -33.79 Million CAD | 54.239% |
| Sernova Corp. | -41.13 Million CAD | 62.405% |